Precision System Science Co., Ltd. (7707.T)

JPY 227.0

(-0.44%)

Long Term Debt Summary of Precision System Science Co., Ltd.

  • Precision System Science Co., Ltd.'s latest annual long term debt in 2023 was 289.67 Million JPY , down -88.52% from previous year.
  • Precision System Science Co., Ltd.'s latest quarterly long term debt in 2023 FY was 289.67 Million JPY , down -88.52% from previous quarter.
  • Precision System Science Co., Ltd. reported annual long term debt of 2.52 Billion JPY in 2022, down -5.6% from previous year.
  • Precision System Science Co., Ltd. reported annual long term debt of 2.67 Billion JPY in 2021, up 108.02% from previous year.
  • Precision System Science Co., Ltd. reported quarterly long term debt of 289.67 Million JPY for 2023 Q4, down -17.93% from previous quarter.
  • Precision System Science Co., Ltd. reported quarterly long term debt of 352.96 Million JPY for 2023 Q3, down -84.34% from previous quarter.

Annual Long Term Debt Chart of Precision System Science Co., Ltd. (2023 - 2007)

Historical Annual Long Term Debt of Precision System Science Co., Ltd. (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 289.67 Million JPY -88.52%
2022 2.52 Billion JPY -5.6%
2021 2.67 Billion JPY 108.02%
2020 1.28 Billion JPY 293.64%
2019 326.32 Million JPY 40.03%
2018 233.03 Million JPY -39.55%
2017 385.51 Million JPY -38.61%
2016 628.01 Million JPY 1.58%
2015 618.27 Million JPY -15.98%
2014 735.87 Million JPY 9.57%
2013 671.58 Million JPY -16.96%
2012 808.74 Million JPY -26.02%
2011 1.09 Billion JPY 33.18%
2010 820.83 Million JPY 27.68%
2009 642.86 Million JPY -14.45%
2008 751.48 Million JPY -19.51%
2007 933.58 Million JPY 0.0%

Peer Long Term Debt Comparison of Precision System Science Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Shin Nippon Biomedical Laboratories, Ltd. 18.14 Billion JPY 98.404%
DNA Chip Research Inc. - JPY -Infinity%
Cosmo Bio Company,Limited - JPY -Infinity%
H.U. Group Holdings, Inc. 60.1 Billion JPY 99.518%
FALCO HOLDINGS Co., Ltd. 148 Million JPY -95.725%
BML, Inc. 3.73 Billion JPY 92.238%
Human Metabolome Technologies, Inc. 11.34 Million JPY -2453.535%